Search Results - "NIEDER, Michael"

Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial by Alexander, Sarah, Fisher, Brian T, Gaur, Aditya H, Dvorak, Christopher C, Villa Luna, Doojduen, Dang, Ha, Chen, Lu, Green, Michael, Nieder, Michael L, Fisher, Beth, Bailey, L. Charles, Wiernikowski, John, Sung, Lillian

“…IMPORTANCE: Bacteremia causes considerable morbidity among children with acute leukemia and those undergoing hematopoietic stem cell transplantation (HSCT)…”
Get full text

Association of body mass index and survival in pediatric leukemia: a meta-analysis by Orgel, Etan, Genkinger, Jeanine M, Aggarwal, Divya, Sung, Lillian, Nieder, Michael, Ladas, Elena J

“…Obesity is a worldwide epidemic in children and adolescents. Adult cohort studies have reported an association between higher body mass index (BMI) and…”
Get full text

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group by MEYERS, Paul A, SCHWARTZ, Cindy L, KLEINERMAN, Eugenie, LINK, Michael P, NADEL, Helen, NIEDER, Michael, SIEGAL, Gene P, WEINER, Michael A, WELLS, Robert J, WOMER, Richard B, GRIER, Holcombe E, KRAILO, Mark D, HEALEY, John H, BERNSTEIN, Mark L, BETCHER, Donna, FERGUSON, William S, GEBHARDT, Mark C, GOORIN, Alien M, HARRIS, Michael

“…To compare three-drug chemotherapy with cisplatin, doxorubicin, and methotrexate with four-drug chemotherapy with cisplatin, doxorubicin, methotrexate, and…”
Get full text

Addition of Muramyl Tripeptide to Chemotherapy for Patients With Newly Diagnosed Metastatic Osteosarcoma: A Report From the Children's Oncology Group by CHOU, Alexander J, KLEINERMAN, Eugenie S, WOMER, Richard B, MEYERS, Paul A, KRAI O, Mark D, ZHENGJIA CHEN, BETCHER, Donna L, HEALEY, John H, CONRAD, Ernest U, NIEDER, Michael L, WEINER, Michael A, WELLS, Robert J

“…The addition of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) to chemotherapy has been shown to improve overall survival in patients with…”
Get full text

Pacritinib Combined with Sirolimus and Low-Dose Tacrolimus for GVHD Prevention after Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results by Pidala, Joseph, Walton, Kelly, Elmariah, Hany, Kim, Jongphil, Mishra, Asmita, Bejanyan, Nelli, Nishihori, Taiga, Khimani, Farhad, Perez, Lia, Faramand, Rawan G, Davila, Marco L, Nieder, Michael L, Sagatys, Elizabeth M, Holtan, Shernan G, Lawrence, Nicholas J, Lawrence, Harshani R, Blazar, Bruce R, Anasetti, Claudio, Sebti, Said M, Betts, Brian C

“…In this first-in-human, phase I, GVHD prevention trial (NCT02891603), we combine pacritinib (PAC), a JAK2 inhibitor, with sirolimus to concurrently reduce…”
Get full text

Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma by Chou, Alexander J., Kleinerman, Eugenie S., Krailo, Mark D., Chen, Zhengjia, Betcher, Donna L., Healey, John H., Conrad, Ernest U., Nieder, Michael L., Weiner, Michael A., Wells, Robert J., Womer, Richard B., Meyers, Paul A.

“…BACKGROUND: The addition of liposomal muramyl tripeptide phosphatidylethanolamine (MTP‐PE) to chemotherapy has been shown to improve overall survival in…”
Get full text

Prospective Evaluation of the Fungitell® (1→3) Beta‐D‐Glucan Assay as a Diagnostic Tool for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplantation: A Report from the Children's Oncology Group by Otto, William R., Dvorak, Christopher C., Boge, Craig L. K., Ostrosky‐Zeichner, Luis, Esbenshade, Adam J., Nieder, Michael L., Alexander, Sarah, Steinbach, William J., Dang, Ha, Villaluna, Doojduen, Chen, Lu, Skeens, Micah, Zaoutis, Theoklis E., Sung, Lillian, Fisher, Brian T.

“…Background Invasive fungal disease (IFD) is a major source of morbidity and mortality for hematopoietic cell transplant (HCT) recipients. Non‐invasive…”
Get full text

Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study by Crowder, Sylvia L, Sauls, Rachel, Redwine, Laura, Nieder, Michael, Albanyan, Omar, Yasin, Hassaan, Khimani, Farhad, Stern, Marilyn

“…Previous adolescent and young adult (AYA) research suggests patients undergoing hematopoietic stem cell transplantation (HSCT) experience severe physiological…”
Get full text

Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group by Seelisch, Jennifer, Sung, Lillian, Kelly, Michael J., Raybin, Jennifer L., Beauchemin, Melissa, Dvorak, Christopher C., Kelly, Katherine Patterson, Nieder, Michael L., Noll, Robert B., Thackray, Jennifer, Ullrich, Nicole J., Cabral, Sandra, Dupuis, L. Lee, Robinson, Paula D.

“…Providing evidence‐based supportive care for children with cancer has the potential to optimize treatment outcomes and improve quality of life. The Children's…”
Get full text

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation by Betts, Brian C, Pidala, Joseph, Kim, Jongphil, Mishra, Asmita, Nishihori, Taiga, Perez, Lia, Ochoa-Bayona, Jose Leonel, Khimani, Farhad, Walton, Kelly, Bookout, Ryan, Nieder, Michael, Khaira, Divis K, Davila, Marco, Alsina, Melissa, Field, Teresa, Ayala, Ernesto, Locke, Frederick L, Riches, Marcie, Kharfan-Dabaja, Mohamed, Fernandez, Hugo, Anasetti, Claudio

“…Graft- -host disease (GvHD) remains a major cause of transplant-related mortality. Interleukin-2 (IL-2) plus sirolimus (SIR) synergistically reduces acute GvHD…”
Get full text

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate by MEYERS, Paul A, SCHWARTZ, Cindy L, HARRIS, Michael B, HEALEY, John, HUVOS, Andrew, LINK, Michael, MONTEBELLO, Joseph, NADEL, Helen, NIEDER, Michael, SATO, Judith, SIEGAL, Gene, WEINER, Michael, KRAILO, Mark, WELLS, Robert, WOLD, Lester, WOMER, Richard, GRIER, Holcombe, KLEINERMAN, Eugenie S, BETCHER, Donna, BERNSTEIN, Mark L, CONRAD, Ernest, FERGUSON, William, GEBHARDT, Mark, GOORIN, Allen M

“…To determine whether the addition of ifosfamide and/or muramyl tripeptide (MTP) encapsulated in liposomes to cisplatin, doxorubicin, and high-dose methotrexate…”
Get full text

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation by Bejanyan, Nelli, Pidala, Joseph A., Wang, Xuefeng, Thapa, Ram, Nishihori, Taiga, Elmariah, Hany, Lazaryan, Aleksandr, Khimani, Farhad, Davila, Marco L., Mishra, Asmita, Faramand, Rawan, Jain, Michael D., Ochoa, Leonel, Perez, Lia Elena, Liu, Hien, Alsina, Melissa, Kharfan-Dabaja, Mohamed A., Fernandez, Hugo, Nieder, Michael L., Locke, Frederick L., Anasetti, Claudio, Ayala, Ernesto

“…The introduction of posttransplant cyclophosphamide (PTCy) made performing allogeneic hematopoietic cell transplantation (HCT) from HLA haplotype–incompatible…”
Get full text

Pediatric HCT in Florida (2014 ‐2016): A report from the FPBCC by Chellapandian, Deepak, Sunkersett, Gauri, Oshrine, Benjamin, Galvez Silva, Jorge, Ziga, Edward, Alperstein, Warren, Joyce, Michael, Katzenstein, Howard, Godder, Kamar, Castillo, Paul, Barredo, Julio, Fort, John, Shaw, Peter H., Nieder, Michael L., Cline, Jessica, Yang, Fan, Horn, Biljana

“…FPBCC was formed in 2018 by five pediatric transplant programs in Florida. One of the key objectives of the consortium is to provide outcome analyses by…”
Get full text

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation by Pidala, Joseph, Beato, Francisca, Kim, Jongphil, Betts, Brian, Jim, Heather, Sagatys, Elizabeth, Levine, John E, Ferrara, James L M, Ozbek, Umut, Ayala, Ernesto, Davila, Marco, Fernandez, Hugo F, Field, Teresa, Kharfan-Dabaja, Mohamed A, Khaira, Divis, Khimani, Farhad, Locke, Frederick L, Mishra, Asmita, Nieder, Michael, Nishihori, Taiga, Perez, Lia, Riches, Marcie, Anasetti, Claudio

“…T-helper 1 and T-helper 17 lymphocytes mediate acute graft- -host disease (GvHD). Interleukin 12 is critical for T-helper 1 differentiation and interleukin 23…”
Get full text

A Randomized Trial of Caspofungin vs Triazoles Prophylaxis for Invasive Fungal Disease in Pediatric Allogeneic Hematopoietic Cell Transplant by Dvorak, Christopher C, Fisher, Brian T, Esbenshade, Adam J, Nieder, Michael L, Alexander, Sarah, Steinbach, William J, Dang, Ha, Villaluna, Doojduen, Chen, Lu, Skeens, Micah, Zaoutis, Theoklis E, Sung, Lillian

“…Children and adolescents undergoing allogeneic hematopoietic cell transplantation (HCT) are at high risk for invasive fungal disease (IFD). This multicenter,…”
Get full text

Feasibility and Toxicity of Full-Body Volumetric Modulated Arc Therapy Technique for High-Dose Total Body Irradiation by Keit, Emily, Liveringhouse, Casey, Figura, Nicholas, Weygand, Joseph, Sandoval, Maria L., Garcia, Genevieve, Peters, Julia, Nieder, Michael, Faramand, Rawan, Khimani, Farhad, Kim, Sungjune, Robinson, Timothy J., Johnstone, Peter A.S., Penagaricano, Jose, Latifi, Kujtim

“…Introduction: High-dose total body irradiation (TBI) is often part of myeloablative conditioning in acute leukemia. Modern volumetric modulated arc therapy…”
Get full text

A pilot study of low-dose anti-angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893 by Felgenhauer, Judy L., Nieder, Michael L., Krailo, Mark D., Bernstein, Mark L., Henry, David W., Malkin, David, Baruchel, Sylvain, Chuba, Paul J., Sailer, Scott L., Brown, Ken, Ranganathan, Sarangarajan, Marina, Neyssa

“…Background The aims of this study were to determine the feasibility of the combination of low dose, anti‐angiogenic chemotherapy with standard therapy for…”
Get full text

ELN 2017 Genetic Risk Stratification Predicts Survival of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation by Hansen, Doris K., Kim, Jongphil, Thompson, Zachary, Hussaini, Mohammad, Nishihori, Taiga, Ahmad, Anam, Elmariah, Hany, Faramand, Rawan, Mishra, Asmita, Davila, Marco L., Khimani, Farhad, Lazaryan, Aleksandr, Sallman, David, Liu, Hien, Perez, Lia E., Fernandez, Hugo, Nieder, Michael L., Lancet, Jeffrey E., Pidala, Joseph A., Anasetti, Claudio, Bejanyan, Nelli

“…European LeukemiaNet (ELN) 2017 risk stratification by genetics is prognostic of outcomes in patients with acute myeloid leukemia (AML). However, the…”
Get full text

Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications by Dibs, Khaled, Sim, Austin J, Peñagaricano, José A, Latifi, Kujtim, Garcia, Genevieve A, Peters, Julia A, Nieder, Michael L, Kim, Sungjune, Robinson, Timothy J

“…The aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a…”
Get full text

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease by Lazaryan, Aleksandr, Lee, Stephanie, Arora, Mukta, Kim, Jongphil, Betts, Brian Christopher, Khimani, Farhad, Nishihori, Taiga, Bejanyan, Nelli, Liu, Hien, Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Gonzalez, Rebecca, Jain, Michael D., Davila, Marco L., Perez, Lia Elena, Mishra, Asmita, Perez Perez, Ariel, Balke, Karlie, Ayala, Ernesto, Ochoa, Leonel, Castaneda Puglianini, Omar, Faramand, Rawan, Alsina, Melissa, Elmariah, Hany, Nieder, Michael L., Fernandez, Hugo, Anasetti, Claudio, Pidala, Joseph A.

“…Standard initial therapy of chronic graft vs. host disease (cGVHD) with glucocorticoids results in suboptimal response. Safety and feasibility of therapy with…”
Get full text